The FDA has halted the emergency use authorization of the monoclonal antibody therapy Evusheld because it does not appear to protect against Covid-19 from viral variants currently circulating in the United States.
Evusheld is a monoclonal antibody therapy used to prevent Covid-19 in immunocompromised people, who are less likely to generate an immune response from Covid-19 vaccination. US officials have warned for months that the antibody therapy was not working against certain emerging variants, but it was still available.
“This means that Evusheld is not expected to provide protection against developing COVID-19 if exposed to those variants,” the FDA said in a statement Thursday. The agency said that if someone becomes infected and develops Covid-19 symptoms, they should seek medical care and may be able to use antivirals Paxlovid, remdesivir or molnupiravir, all of which work against currently circulating variants.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
FDA Wants Annual COVID Boosters, Just Like Annual Flu ShotsHealth officials want to simplify the recommended COVID-19 vaccine protocol, making it more like the process for annual flu shots.
Consulte Mais informação »
The FDA Wants an Annual COVID Vaccine: What You Need to KnowA national advisory committee is expected to vote Thursday on whether Americans should pivot to an annual COVID-19 shot (like a flu shot) vs. periodic booster shots. WebMD asks health experts your most pressing questions about a possible switch to a yearly shot.
Consulte Mais informação »
The FDA Considers New Plan of Administering COVID-19 VaccinesThe Food and Drug Administration is considering a shift to a new way of administering the COVID-19 vaccine that is akin to receiving the flu shot. The FDA’s vaccine advisory committee will meet Thursday to discuss this proposed change, as well as other updates concerning the status of current and...
Consulte Mais informação »
FDA Wants Annual COVID Vaccinations Just Like Annual Flu Shots– U.S. health officials want to simplify the recommended COVID-19 vaccine protocol, making it more like the process for annual flu shots with a single annual shot.
Consulte Mais informação »
FDA rethinks its strategy on future COVID vaccinesAn FDA advisory panel meeting tomorrow could set the stage for a reset of how the U.S. approaches its COVID-19 vaccine strategy.
Consulte Mais informação »